← Back to Search

Behavioural Intervention

rTMS for Obsessive-Compulsive Disorder

N/A

Waitlist Available

Led By Sarah Garnaat, PhD

Research Sponsored by Butler Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before rtms and within 30 minutes immediately following rtms

Awards & highlights

Study Summary

This trial looks at whether a certain kind of brain stimulation can help people with OCD with a particular kind of task.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before rtms and within 30 minutes immediately following rtms

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before rtms and within 30 minutes immediately following rtms

This trial's timeline: 3 weeks for screening, Varies for treatment, and before rtms and within 30 minutes immediately following rtms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Other outcome measures

Change in regional activation in anterior cingulate cortex

Change in regional activation in dorsolateral prefrontal cortex

Change in regional activation in orbitofrontal cortex

+3 more

Trial Design

7Treatment groups

Experimental Treatment

Placebo Group

Group I: OCD, Active TMS (3 session)Experimental Treatment1 Intervention

Participants with OCD who receive 3 sessions of active, open-label rTMS

Group II: OCD, Active TMSExperimental Treatment1 Intervention

Participants with OCD who receive active rTMS

Group III: Healthy Control, Sham TMSExperimental Treatment1 Intervention

Healthy control participants who receive sham rTMS

Group IV: Healthy Control, Active TMS (3 sessions)Experimental Treatment1 Intervention

Healthy control participants who receive 3 sessions of active, open-label rTMS

Group V: Healthy Control, Active TMS (1 session)Experimental Treatment1 Intervention

Healthy control participants who receive 1 session of active, open-label rTMS

Group VI: Healthy Control, Active TMSExperimental Treatment1 Intervention

Healthy control participants who receive active rTMS

Group VII: OCD, Sham TMSPlacebo Group1 Intervention

Participants with OCD who receive sham rTMS

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

sham rTMS

2010

Completed Phase 3

~310

rTMS

2016

Completed Phase 3

~840

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor

129 Previous Clinical Trials

16,350 Total Patients Enrolled

12 Trials studying Obsessive-Compulsive Disorder

379 Patients Enrolled for Obsessive-Compulsive Disorder

Sarah Garnaat, PhDPrincipal InvestigatorButler Hospital

2 Previous Clinical Trials

13 Total Patients Enrolled

1 Trials studying Obsessive-Compulsive Disorder

13 Patients Enrolled for Obsessive-Compulsive Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the current medical experiment have an age restriction of 55 years or less?

"This clinical trial is seeking patients who are above the age of majority and below 55 years old."

Answered by AI

How many subjects are partaking in this experiment?

"Affirmative. Data posted on clinicaltrials.gov affirms that this experiment is presently recruiting patients, having first been published November 15th 2019 and last updated August 4th 2022. The research requires 98 subjects to be sourced from 1 facility."

Answered by AI

Are any participants being added to this research endeavor at present?

"Affirmative. As per the clinicaltrials.gov page, recruitment for this medical trial is ongoing since its posting on November 15th 2019 and most recent update on August 4th 2022. 98 participants are sought after across 1 location."

Answered by AI